Olopatadine HCL 0.1% Ophthalmic Solution

From: Federal Government(Federal)
SPE2D222R0117

Basic Details

started - 24 Aug, 2023 (8 months ago)

Start Date

24 Aug, 2023 (8 months ago)
due - 15 Feb, 2028 (in about 3 years)

Due Date

15 Feb, 2028 (in about 3 years)
Award

Type

Award
SPE2D222R0117

Identifier

SPE2D222R0117
DEPT OF DEFENSE

Customer / Agency

DEPT OF DEFENSE (710996)DEFENSE LOGISTICS AGENCY (DLA) (282538)TROOP SUPPORT MEDICAL (2678)DLA TROOP SUPPORT (32713)
DEPT OF DEFENSE

Supplier

GOLDEN STATE MEDICAL SUPPLY INC (Camarillo, California) Awarded: Feb 15, 2023Contract Value : $17,621,454.00

Attachments (4)

unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023.Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML

Location

Place Of Performance : N/A

Country : CANADAState : CanadaCity : Ontario

You may also like

PHARMACY ORDER OF BALVERSA 4MG TABS FOR PATIENT CARE.

Due: 07 May, 2024 (in 2 days)Agency: VETERANS AFFAIRS, DEPARTMENT OF

MEDSTATION

Due: 18 Jun, 2024 (in 1 month)Agency: VETERANS AFFAIRS, DEPARTMENT OF

Please Sign In to see more like these.

Don't have an account yet? Create a free account now.

Classification

naicsCode 325412Pharmaceutical Preparation Manufacturing
pscCode 6505Drugs and Biologicals